BioPharma Credit (LON:BPCP) Trading 1.5% Higher – Should You Buy?

Shares of BioPharma Credit PLC (LON:BPCPGet Free Report) rose 1.5% on Friday . The company traded as high as GBX 68.30 ($0.86) and last traded at GBX 68.09 ($0.86). Approximately 4,307 shares changed hands during trading, a decline of 82% from the average daily volume of 23,759 shares. The stock had previously closed at GBX 67.10 ($0.85).

BioPharma Credit Price Performance

The stock has a market capitalization of £932.78 million, a P/E ratio of 1,134.77 and a beta of 0.22. The firm has a 50 day moving average of GBX 67.67 and a 200-day moving average of GBX 69.09.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Recommended Stories

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.